Clinical Trial

Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this research is to study the efficacy and safety of daily, home-based hyperthermic baths for reducing epileptic seizures in CDKL5 Deficiency Disorder.
Trial Details
NCT Number NCT07602205
Lead Sponsor Xuanwu Hospital, Beijing
Conditions CDKL5 Deficiency Disorder
Enrollment 34 participants
Start Date 2026-08-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22